<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019fe3d7-de43-739d-8b45-538b0fead8d6,g:2877b228-cfa7-4122-b752-44a11617fa3e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="dnli-20260930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019fe3d7-dfba-772e-840f-40e999daf3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019fe3d7-dfba-76f4-8077-f7973e4a197b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019fe3d7-dfba-772e-840f-40e999daf3b5" xlink:to="loc_us-gaap_LiabilitiesCurrent_019fe3d7-dfba-76f4-8077-f7973e4a197b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019fe3d7-dfba-77f3-86d5-b7f3a4d449ba" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019fe3d7-dfba-772e-840f-40e999daf3b5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019fe3d7-dfba-77f3-86d5-b7f3a4d449ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_019fe3d7-dfba-7d5e-be89-e3e94c41558f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019fe3d7-dfba-772e-840f-40e999daf3b5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_019fe3d7-dfba-7d5e-be89-e3e94c41558f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_RoyaltyFundingArrangementLiabilityNoncurrent_019fe3d7-dfba-7327-afbb-2f96cc89ec20" xlink:href="dnli-20260930.xsd#dnli_RoyaltyFundingArrangementLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019fe3d7-dfba-772e-840f-40e999daf3b5" xlink:to="loc_dnli_RoyaltyFundingArrangementLiabilityNoncurrent_019fe3d7-dfba-7327-afbb-2f96cc89ec20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019fe3d7-dfba-75f4-911c-8b687b1e6761" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019fe3d7-dfba-794c-ad12-b051039c844a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019fe3d7-dfba-75f4-911c-8b687b1e6761" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019fe3d7-dfba-794c-ad12-b051039c844a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_019fe3d7-dfba-786c-bb0b-098cc88a2df5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019fe3d7-dfba-75f4-911c-8b687b1e6761" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_019fe3d7-dfba-786c-bb0b-098cc88a2df5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019fe3d7-dfba-7dd1-b214-e37371468a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019fe3d7-dfba-75f4-911c-8b687b1e6761" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019fe3d7-dfba-7dd1-b214-e37371468a5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019fe3d7-dfba-7d4e-9b90-18d6fb0b5a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019fe3d7-dfba-75f4-911c-8b687b1e6761" xlink:to="loc_us-gaap_InventoryNet_019fe3d7-dfba-7d4e-9b90-18d6fb0b5a6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019fe3d7-dfba-7d9c-b9be-2e8c40e9324e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019fe3d7-dfba-75f4-911c-8b687b1e6761" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019fe3d7-dfba-7d9c-b9be-2e8c40e9324e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019fe3d7-dfba-72b2-9b37-c4abb3ae7c05" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019fe3d7-dfba-72d0-a7d0-30549057f8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019fe3d7-dfba-72b2-9b37-c4abb3ae7c05" xlink:to="loc_us-gaap_Liabilities_019fe3d7-dfba-72d0-a7d0-30549057f8dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019fe3d7-dfba-7487-ab36-ad28abe6520a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019fe3d7-dfba-72b2-9b37-c4abb3ae7c05" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019fe3d7-dfba-7487-ab36-ad28abe6520a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019fe3d7-dfba-7bb5-8b24-c1a284867cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019fe3d7-dfba-72b2-9b37-c4abb3ae7c05" xlink:to="loc_us-gaap_StockholdersEquity_019fe3d7-dfba-7bb5-8b24-c1a284867cf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019fe3d7-dfba-71d6-b1de-050e4ed28f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019fe3d7-dfba-7933-acaa-6a3dd2d1f65a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019fe3d7-dfba-71d6-b1de-050e4ed28f0a" xlink:to="loc_us-gaap_AssetsCurrent_019fe3d7-dfba-7933-acaa-6a3dd2d1f65a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_019fe3d7-dfba-77ae-a884-f5d12d3edda5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019fe3d7-dfba-71d6-b1de-050e4ed28f0a" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_019fe3d7-dfba-77ae-a884-f5d12d3edda5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019fe3d7-dfba-70f9-81c6-3274f5af88d8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019fe3d7-dfba-71d6-b1de-050e4ed28f0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019fe3d7-dfba-70f9-81c6-3274f5af88d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_019fe3d7-dfba-72c2-aa13-66cc55549c79" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019fe3d7-dfba-71d6-b1de-050e4ed28f0a" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_019fe3d7-dfba-72c2-aa13-66cc55549c79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019fe3d7-dfba-7091-a1ca-985a34770ded" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019fe3d7-dfba-71d6-b1de-050e4ed28f0a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019fe3d7-dfba-7091-a1ca-985a34770ded" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019fe3d7-dfba-7530-b595-de261ffdfb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019fe3d7-dfba-71d6-b1de-050e4ed28f0a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_019fe3d7-dfba-7530-b595-de261ffdfb1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019fe3d7-dfba-7578-bb41-838590482450" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019fe3d7-dfba-71d6-b1de-050e4ed28f0a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019fe3d7-dfba-7578-bb41-838590482450" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019fe3d7-dfba-7a9f-8fd3-58c77efa89ff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019fe3d7-dfba-754f-aab2-74a21cbc4d21" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019fe3d7-dfba-7a9f-8fd3-58c77efa89ff" xlink:to="loc_us-gaap_AccountsPayableCurrent_019fe3d7-dfba-754f-aab2-74a21cbc4d21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019fe3d7-dfba-7e38-b586-cbc6e3a75c26" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019fe3d7-dfba-7a9f-8fd3-58c77efa89ff" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019fe3d7-dfba-7e38-b586-cbc6e3a75c26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019fe3d7-dfba-7532-b3f0-4caba50d0f00" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_019fe3d7-dfba-7d78-8057-b8d7b0793b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019fe3d7-dfba-7532-b3f0-4caba50d0f00" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_019fe3d7-dfba-7d78-8057-b8d7b0793b2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_019fe3d7-dfba-791f-926b-e6252ea39e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019fe3d7-dfba-7532-b3f0-4caba50d0f00" xlink:to="loc_us-gaap_CommonStockValueOutstanding_019fe3d7-dfba-791f-926b-e6252ea39e5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019fe3d7-dfba-7efe-a07d-de33bd737114" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019fe3d7-dfba-7532-b3f0-4caba50d0f00" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019fe3d7-dfba-7efe-a07d-de33bd737114" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019fe3d7-dfba-72a4-bd85-77eac4b15695" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019fe3d7-dfba-7532-b3f0-4caba50d0f00" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019fe3d7-dfba-72a4-bd85-77eac4b15695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019fe3d7-dfba-7286-b2e3-bbc865cb15b2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019fe3d7-dfba-7532-b3f0-4caba50d0f00" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019fe3d7-dfba-7286-b2e3-bbc865cb15b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="dnli-20260930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveIncomeLossUnaudited"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveIncomeLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_01a115b1-5de0-789b-b15a-ab176efeb4d7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_01a115b1-5de0-7296-8bcc-34c2ac6f12ed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_01a115b1-5de0-789b-b15a-ab176efeb4d7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_01a115b1-5de0-7296-8bcc-34c2ac6f12ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_01a115b1-5de0-7f38-8182-ec44b08d2458" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_01a115b1-5de0-789b-b15a-ab176efeb4d7" xlink:to="loc_us-gaap_InterestAndOtherIncome_01a115b1-5de0-7f38-8182-ec44b08d2458" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019fe3d7-dfba-7f8a-b912-4de1ab3a15c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_019fe3d7-dfba-7d79-9107-ce7824862834" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019fe3d7-dfba-7f8a-b912-4de1ab3a15c2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_019fe3d7-dfba-7d79-9107-ce7824862834" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019fe3d7-dfba-79ab-8c09-b8ed2b00b85c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019fe3d7-dfba-7f8a-b912-4de1ab3a15c2" xlink:to="loc_us-gaap_NetIncomeLoss_019fe3d7-dfba-79ab-8c09-b8ed2b00b85c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019fe3d7-dfba-7604-8693-ff7f8cfcb234" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_019fe3d7-dfba-7d59-a9fa-4832e0f029fe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019fe3d7-dfba-7604-8693-ff7f8cfcb234" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_019fe3d7-dfba-7d59-a9fa-4832e0f029fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019fe3d7-dfba-7a8a-b730-8c4fdd488443" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019fe3d7-dfba-7604-8693-ff7f8cfcb234" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019fe3d7-dfba-7a8a-b730-8c4fdd488443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019fe3d7-dfba-75c6-b6d2-a7bef78a5fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019fe3d7-dfba-7604-8693-ff7f8cfcb234" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019fe3d7-dfba-75c6-b6d2-a7bef78a5fc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_019fe3d7-dfba-736a-bd16-fa8e5aa383fc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_019fe3d7-dfba-7604-8693-ff7f8cfcb234" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_019fe3d7-dfba-736a-bd16-fa8e5aa383fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019fe3d7-dfba-71e0-88d0-03363cff5502" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_019fe3d7-dfba-7217-9f91-41d136f881b6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019fe3d7-dfba-71e0-88d0-03363cff5502" xlink:to="loc_us-gaap_CostsAndExpenses_019fe3d7-dfba-7217-9f91-41d136f881b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019fe3d7-dfba-7687-bfad-68045de04920" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019fe3d7-dfba-71e0-88d0-03363cff5502" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019fe3d7-dfba-7687-bfad-68045de04920" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019fe3d7-dfba-79cc-b5ae-755be182674a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019fe3d7-dfba-7968-8e4b-b17557a63dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019fe3d7-dfba-79cc-b5ae-755be182674a" xlink:to="loc_us-gaap_OperatingIncomeLoss_019fe3d7-dfba-7968-8e4b-b17557a63dc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_01a0f7ce-33d6-7b48-bda4-e0a9792b20fd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019fe3d7-dfba-79cc-b5ae-755be182674a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_01a0f7ce-33d6-7b48-bda4-e0a9792b20fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="dnli-20260930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019fe3d7-dfba-7bc8-94fc-3b5178300b06" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-73e6-ba7a-27c77ff1a1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019fe3d7-dfba-7bc8-94fc-3b5178300b06" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-73e6-ba7a-27c77ff1a1d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fe3d7-dfba-751c-a76a-74f3f68fb565" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019fe3d7-dfba-7bc8-94fc-3b5178300b06" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fe3d7-dfba-751c-a76a-74f3f68fb565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fe3d7-dfba-799d-95ec-820f846a59ea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019fe3d7-dfba-7bc8-94fc-3b5178300b06" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fe3d7-dfba-799d-95ec-820f846a59ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fe3d7-dfba-756d-a719-d7ee2df9c6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_019fe3d7-dfba-73af-b218-e4c40d815276" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fe3d7-dfba-756d-a719-d7ee2df9c6c9" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_019fe3d7-dfba-73af-b218-e4c40d815276" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_019fe3d7-dfba-7c42-8f00-f213aeab641e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fe3d7-dfba-756d-a719-d7ee2df9c6c9" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_019fe3d7-dfba-7c42-8f00-f213aeab641e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019fe3d7-dfba-7c2a-9b17-502f9a5be494" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fe3d7-dfba-756d-a719-d7ee2df9c6c9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019fe3d7-dfba-7c2a-9b17-502f9a5be494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019fe3d7-dfba-7ec7-8d38-4f39e27ecbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fe3d7-dfba-756d-a719-d7ee2df9c6c9" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019fe3d7-dfba-7ec7-8d38-4f39e27ecbcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_01a0f7d4-0021-7d0b-bcb3-b6fae336f580" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019fe3d7-dfba-756d-a719-d7ee2df9c6c9" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_01a0f7d4-0021-7d0b-bcb3-b6fae336f580" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fe3d7-dfba-7b96-a180-5c47d34b88da" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019fe3d7-dfba-7191-99ba-bb16545f62e0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fe3d7-dfba-7b96-a180-5c47d34b88da" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019fe3d7-dfba-7191-99ba-bb16545f62e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_ProceedsFromSaleOfRevenueParticipationRight_019fe3d7-dfba-70c5-87ee-1420b9751811" xlink:href="dnli-20260930.xsd#dnli_ProceedsFromSaleOfRevenueParticipationRight"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fe3d7-dfba-7b96-a180-5c47d34b88da" xlink:to="loc_dnli_ProceedsFromSaleOfRevenueParticipationRight_019fe3d7-dfba-70c5-87ee-1420b9751811" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_019fe3d7-dfba-77aa-a28d-3a68af359b33" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fe3d7-dfba-7b96-a180-5c47d34b88da" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_019fe3d7-dfba-77aa-a28d-3a68af359b33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_019fe3d7-dfba-7546-beb1-9b28a26ffcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019fe3d7-dfba-7b96-a180-5c47d34b88da" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_019fe3d7-dfba-7546-beb1-9b28a26ffcc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019fe3d7-dfba-77ba-84e0-5e9ab25168e7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_NetIncomeLoss_019fe3d7-dfba-77ba-84e0-5e9ab25168e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019fe3d7-dfba-789a-a398-2269e9cbebfb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019fe3d7-dfba-789a-a398-2269e9cbebfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019fe3d7-dfba-7175-9c2e-3a71ac673b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_ShareBasedCompensation_019fe3d7-dfba-7175-9c2e-3a71ac673b6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfDiscount_019fe3d7-dfba-7ed5-9acf-98bfc6c10683" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeAmortizationOfDiscount"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfDiscount_019fe3d7-dfba-7ed5-9acf-98bfc6c10683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_IncreaseDecreaseInNonCashOperatingLeaseExpense_019fe3d7-dfba-733f-9b7d-fa4a825e5a84" xlink:href="dnli-20260930.xsd#dnli_IncreaseDecreaseInNonCashOperatingLeaseExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_dnli_IncreaseDecreaseInNonCashOperatingLeaseExpense_019fe3d7-dfba-733f-9b7d-fa4a825e5a84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_019fe3d7-dfba-7a5b-8d96-bdc741359e11" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_019fe3d7-dfba-7a5b-8d96-bdc741359e11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_RoyaltyFundingArrangementNoncashInterestExpense_019fe3d7-dfba-74f4-946a-ebb8bdda75b1" xlink:href="dnli-20260930.xsd#dnli_RoyaltyFundingArrangementNoncashInterestExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_dnli_RoyaltyFundingArrangementNoncashInterestExpense_019fe3d7-dfba-74f4-946a-ebb8bdda75b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_019fe3d7-dfba-7f09-a681-56903d18b25d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_019fe3d7-dfba-7f09-a681-56903d18b25d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019fe3d7-dfba-7cd7-8ca6-383962ebc91e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019fe3d7-dfba-7cd7-8ca6-383962ebc91e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_019fe3d7-dfba-79d6-9b23-7d17ecc4058e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_019fe3d7-dfba-79d6-9b23-7d17ecc4058e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019fe3d7-dfba-79b0-b0c0-1678d7452504" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019fe3d7-dfba-79b0-b0c0-1678d7452504" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019fe3d7-dfba-7a6f-83ef-96509e1d5189" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019fe3d7-dfba-7a6f-83ef-96509e1d5189" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019fe3d7-dfba-7798-8019-004324d4b768" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019fe3d7-dfba-7798-8019-004324d4b768" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019fe3d7-dfba-7137-9bba-ca27cdb5ab99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019fe3d7-dfba-7137-9bba-ca27cdb5ab99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_IncreaseDecreaseInDeferredLiabilityCapitalizedResearchAndDevelopmentCosts_019fe3d7-dfba-7898-851b-a03588822e15" xlink:href="dnli-20260930.xsd#dnli_IncreaseDecreaseInDeferredLiabilityCapitalizedResearchAndDevelopmentCosts"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_dnli_IncreaseDecreaseInDeferredLiabilityCapitalizedResearchAndDevelopmentCosts_019fe3d7-dfba-7898-851b-a03588822e15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_01a0f7d2-c4e4-74d2-bba7-b330ab63c98f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019fe3d7-dfba-7dca-af43-a4c4846012fb" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_01a0f7d2-c4e4-74d2-bba7-b330ab63c98f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dnli-20260930.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019fe3d7-dfbb-729f-82e4-91fff628f805" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019fe3d7-dfbb-755b-a28f-00e726a13f10" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019fe3d7-dfbb-729f-82e4-91fff628f805" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019fe3d7-dfbb-755b-a28f-00e726a13f10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019fe3d7-dfbb-7dce-bfd0-397e98a95866" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019fe3d7-dfbb-729f-82e4-91fff628f805" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019fe3d7-dfbb-7dce-bfd0-397e98a95866" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_019fe3d7-dfbb-7fac-a957-3d10be403714" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019fe3d7-dfbb-729f-82e4-91fff628f805" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_019fe3d7-dfbb-7fac-a957-3d10be403714" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/MarketableSecuritiesScheduleofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="dnli-20260930.xsd#MarketableSecuritiesScheduleofAvailableforSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/MarketableSecuritiesScheduleofAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019fe3d7-dfbb-727e-a537-749efa4b4012" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019fe3d7-dfbb-773e-8818-9b7a614c2a08" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019fe3d7-dfbb-727e-a537-749efa4b4012" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019fe3d7-dfbb-773e-8818-9b7a614c2a08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019fe3d7-dfbb-76cd-b3c0-55627270ff02" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019fe3d7-dfbb-727e-a537-749efa4b4012" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019fe3d7-dfbb-76cd-b3c0-55627270ff02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019fe3d7-dfbb-72b0-9c66-90b7c789ceb8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019fe3d7-dfbb-727e-a537-749efa4b4012" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019fe3d7-dfbb-72b0-9c66-90b7c789ceb8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/InventoryDetails" xlink:type="simple" xlink:href="dnli-20260930.xsd#InventoryDetails"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_019fe3d7-dfbb-7c1d-882b-ceacba5fe785" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_019fe3d7-dfbb-7634-b781-7a410071d793" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019fe3d7-dfbb-7c1d-882b-ceacba5fe785" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_019fe3d7-dfbb-7634-b781-7a410071d793" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_019fe3d7-dfbb-7ea0-bb67-b4e642d758f9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019fe3d7-dfbb-7c1d-882b-ceacba5fe785" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_019fe3d7-dfbb-7ea0-bb67-b4e642d758f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_019fe3d7-dfbb-743b-8a01-5407378cbaff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_019fe3d7-dfbb-7c1d-882b-ceacba5fe785" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_019fe3d7-dfbb-743b-8a01-5407378cbaff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/IntangibleAssetsScheduleofFutureAnnualAmortizationExpenseDetails" xlink:type="simple" xlink:href="dnli-20260930.xsd#IntangibleAssetsScheduleofFutureAnnualAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/IntangibleAssetsScheduleofFutureAnnualAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019fe3d7-dfbb-79df-a127-aab9dbb72956" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_019fe3d7-dfbb-7da9-807d-2ded0831b690" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019fe3d7-dfbb-79df-a127-aab9dbb72956" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_019fe3d7-dfbb-7da9-807d-2ded0831b690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_019fe3d7-dfbb-7e0e-a425-174fe052171d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019fe3d7-dfbb-79df-a127-aab9dbb72956" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_019fe3d7-dfbb-7e0e-a425-174fe052171d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_019fe3d7-dfbb-7723-9294-b489ebeea11b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019fe3d7-dfbb-79df-a127-aab9dbb72956" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_019fe3d7-dfbb-7723-9294-b489ebeea11b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_019fe3d7-dfbb-7e56-9435-86644b9f3e63" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019fe3d7-dfbb-79df-a127-aab9dbb72956" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_019fe3d7-dfbb-7e56-9435-86644b9f3e63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_019fe3d7-dfbb-79e9-9ed2-4b2d3ea9cbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019fe3d7-dfbb-79df-a127-aab9dbb72956" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_019fe3d7-dfbb-79e9-9ed2-4b2d3ea9cbd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_IntangibleAssetFiniteLivedEstimatedAmortizationExpenseAfterYearFour_019fe3d7-dfbb-7cac-82fa-a88b4152dd44" xlink:href="dnli-20260930.xsd#dnli_IntangibleAssetFiniteLivedEstimatedAmortizationExpenseAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019fe3d7-dfbb-79df-a127-aab9dbb72956" xlink:to="loc_dnli_IntangibleAssetFiniteLivedEstimatedAmortizationExpenseAfterYearFour_019fe3d7-dfbb-7cac-82fa-a88b4152dd44" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="dnli-20260930.xsd#BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/BalanceSheetComponentsScheduleofAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019fe3d7-dfbb-7a48-85ca-bb8a0b225247" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019fe3d7-dfbb-7d9c-b451-7c0a6370a223" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019fe3d7-dfbb-7a48-85ca-bb8a0b225247" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019fe3d7-dfbb-7d9c-b451-7c0a6370a223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_AccruedClinicalAndOtherAccruedResearchAndDevelopmentCosts_019fe3d7-dfbb-7128-902f-8f0b0f5858ba" xlink:href="dnli-20260930.xsd#dnli_AccruedClinicalAndOtherAccruedResearchAndDevelopmentCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019fe3d7-dfbb-7a48-85ca-bb8a0b225247" xlink:to="loc_dnli_AccruedClinicalAndOtherAccruedResearchAndDevelopmentCosts_019fe3d7-dfbb-7128-902f-8f0b0f5858ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_AccruedManufacturingCosts_019fe3d7-dfbb-7e97-acd6-88d68367c48c" xlink:href="dnli-20260930.xsd#dnli_AccruedManufacturingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019fe3d7-dfbb-7a48-85ca-bb8a0b225247" xlink:to="loc_dnli_AccruedManufacturingCosts_019fe3d7-dfbb-7e97-acd6-88d68367c48c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019fe3d7-dfbb-780f-af7a-a175a33aa538" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019fe3d7-dfbb-7a48-85ca-bb8a0b225247" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019fe3d7-dfbb-780f-af7a-a175a33aa538" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_019fe3d7-dfbb-7653-b780-a525d75b44bf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019fe3d7-dfbb-7a48-85ca-bb8a0b225247" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_019fe3d7-dfbb-7653-b780-a525d75b44bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_DeferredResearchAndDevelopmentFundingLiabilityCurrent_019fe3d7-dfbb-7888-b9f3-9b1248344ef7" xlink:href="dnli-20260930.xsd#dnli_DeferredResearchAndDevelopmentFundingLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019fe3d7-dfbb-7a48-85ca-bb8a0b225247" xlink:to="loc_dnli_DeferredResearchAndDevelopmentFundingLiabilityCurrent_019fe3d7-dfbb-7888-b9f3-9b1248344ef7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019fe3d7-dfbb-7204-a8ce-a27732802b95" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019fe3d7-dfbb-7a48-85ca-bb8a0b225247" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019fe3d7-dfbb-7204-a8ce-a27732802b95" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/CommitmentsandContingenciesScheduleofSummarizesLeaseCostsDetails" xlink:type="simple" xlink:href="dnli-20260930.xsd#CommitmentsandContingenciesScheduleofSummarizesLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/CommitmentsandContingenciesScheduleofSummarizesLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_019fe3d7-dfbb-7f18-80f1-c8f58232308c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_019fe3d7-dfbb-7437-bcfa-a97f985324df" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_019fe3d7-dfbb-7f18-80f1-c8f58232308c" xlink:to="loc_us-gaap_OperatingLeaseCost_019fe3d7-dfbb-7437-bcfa-a97f985324df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_019fe3d7-dfbb-7106-bf98-e2b9fb0c486d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_019fe3d7-dfbb-7f18-80f1-c8f58232308c" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_019fe3d7-dfbb-7106-bf98-e2b9fb0c486d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_019fe3d7-dfbb-7894-85ee-d941ddd88a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_019fe3d7-dfbb-7f18-80f1-c8f58232308c" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_019fe3d7-dfbb-7894-85ee-d941ddd88a0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_019fe3d7-dfbb-7d1f-98b9-06193943a01a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_019fe3d7-dfbb-7f18-80f1-c8f58232308c" xlink:to="loc_us-gaap_VariableLeaseCost_019fe3d7-dfbb-7d1f-98b9-06193943a01a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/NetIncomeLossPerShareScheduleofComputationofBasicandDilutedNetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="dnli-20260930.xsd#NetIncomeLossPerShareScheduleofComputationofBasicandDilutedNetIncomeLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/NetIncomeLossPerShareScheduleofComputationofBasicandDilutedNetIncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019fe3d7-dfbb-778e-a67e-22defa51ac8f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_019fe3d7-dfbb-7616-995c-6aff56af19b3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019fe3d7-dfbb-778e-a67e-22defa51ac8f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_019fe3d7-dfbb-7616-995c-6aff56af19b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_019fe3d7-dfbb-7bba-a076-357b289065ae" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019fe3d7-dfbb-778e-a67e-22defa51ac8f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_019fe3d7-dfbb-7bba-a076-357b289065ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019fe3d7-dfbb-77b3-a273-0788f5792dea" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019fe3d7-dfbb-7b63-a3c9-07a2482fbeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019fe3d7-dfbb-77b3-a273-0788f5792dea" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_019fe3d7-dfbb-7b63-a3c9-07a2482fbeaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_019fe3d7-dfbb-707c-8d3a-00e1f4c0bf74" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_019fe3d7-dfbb-77b3-a273-0788f5792dea" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_019fe3d7-dfbb-707c-8d3a-00e1f4c0bf74" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.denalitherapeutics.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="dnli-20260930.xsd#SegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.denalitherapeutics.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_019fe3d7-e07b-7445-973c-37a2ce790119" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_019fe3d7-e07b-7583-bdb8-191e71ab840e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_019fe3d7-e07b-7445-973c-37a2ce790119" xlink:to="loc_us-gaap_InterestAndOtherIncome_019fe3d7-e07b-7583-bdb8-191e71ab840e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_01a10b76-92aa-7449-afff-34d947acc970" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_019fe3d7-e07b-7445-973c-37a2ce790119" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_01a10b76-92aa-7449-afff-34d947acc970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019fe3d7-e07b-7715-a618-9ee3644d3abc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_019fe3d7-e07b-7445-973c-37a2ce790119" xlink:to="loc_us-gaap_OperatingIncomeLoss_019fe3d7-e07b-7715-a618-9ee3644d3abc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019fe3d7-e07b-7a91-8ede-88a0bb438aed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_ExternalResearchAndDevelopmentExpense_019fe3d7-e07b-77cb-a019-78f2cd04cab9" xlink:href="dnli-20260930.xsd#dnli_ExternalResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019fe3d7-e07b-7a91-8ede-88a0bb438aed" xlink:to="loc_dnli_ExternalResearchAndDevelopmentExpense_019fe3d7-e07b-77cb-a019-78f2cd04cab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherResearchAndDevelopmentExpense_019fe3d7-e07b-7899-bf7d-2731f51321c4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019fe3d7-e07b-7a91-8ede-88a0bb438aed" xlink:to="loc_us-gaap_OtherResearchAndDevelopmentExpense_019fe3d7-e07b-7899-bf7d-2731f51321c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_PersonnelRelatedResearchAndDevelopmentExpense_019fe3d7-e07b-778c-b465-6e5aa3490c91" xlink:href="dnli-20260930.xsd#dnli_PersonnelRelatedResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019fe3d7-e07b-7a91-8ede-88a0bb438aed" xlink:to="loc_dnli_PersonnelRelatedResearchAndDevelopmentExpense_019fe3d7-e07b-778c-b465-6e5aa3490c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019fe3d7-e07b-7df2-90b5-49b086f2f719" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_dnli_PersonnelRelatedSellingGeneralAndAdministrativeExpense_019fe3d7-e07b-7597-abf1-4e20dd60b9ee" xlink:href="dnli-20260930.xsd#dnli_PersonnelRelatedSellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019fe3d7-e07b-7df2-90b5-49b086f2f719" xlink:to="loc_dnli_PersonnelRelatedSellingGeneralAndAdministrativeExpense_019fe3d7-e07b-7597-abf1-4e20dd60b9ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSellingGeneralAndAdministrativeExpense_019fe3d7-e07b-7cf6-b36c-1829be62eac2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019fe3d7-e07b-7df2-90b5-49b086f2f719" xlink:to="loc_us-gaap_OtherSellingGeneralAndAdministrativeExpense_019fe3d7-e07b-7cf6-b36c-1829be62eac2" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
